The Rise of Anti-CD47 Drugs Market: A New Era in Cancer Treatment

Thu, 30 Jan 2025 07:29:37 +0000

The anti CD47 drugs market comprises CD47 targeting therapies that deliver promising outcomes in oncology. CD47 is a cell surface receptor that acts as a "don't eat me" signal to macrophages and other immune cells. Various cancer cells overexpress CD47 to evade phagocytosis by macrophages.